-
TXNL1–Proteasome Binding and Stress-Induced Degradation
2026-08-15
The reference study defines how thioredoxin-like protein 1 (TXNL1) binds the human 19S proteasome and undergoes ubiquitin-independent degradation during metal- or metalloid-associated oxidative stress. Its cryo-EM structure links a previously uncharacterized proteasome-binding mode to specific contacts with PSMD1, PSMD4, and PSMD14, providing a structural framework for studying stress-regulated proteostasis.
-
mRNA Rescue of Niemann-Pick C1 in Patient Fibroblasts
2026-08-14
This preprint shows that engineered NPC1 mRNA can restore cholesterol handling and reduce lysosomal abnormalities in fibroblasts derived from a patient with Niemann-Pick disease type C1. Its central technical finding is that GC3 codon optimization combined with N1-Methylpseudouridine produced markedly stronger reporter expression than unmodified mRNA, supporting a rational strategy for mRNA modification for protein expression.
-
N1-Methylpseudouridine for Cardiac mRNA Studies
2026-08-14
N1-Methylpseudouridine supports high-output, lower-innate-activation mRNA experiments in cardiomyocyte and mitochondrial disease models. This practical guide connects modified mRNA design with the HEY2 metabolic pathway and provides workflow controls for translation, viability, and mitochondrial readouts.
-
N1-Methyl-Pseudouridine-5'-Triphosphate for RNA
2026-08-13
Use N1-Methyl-Pseudouridine-5'-Triphosphate to systematically optimize RNA stability, translation, and in vitro transcription workflows. This guide connects bench-scale modified RNA production with emerging inhaled LNP strategies for cancer immunotherapy while clearly separating established evidence from experimental opportunities.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-08-13
The reference study shows that ATRX-deficient high-grade glioma cells are more vulnerable to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient counterparts. Its drug-screening and combination data support incorporating ATRX status into interpretation of RTK inhibitor studies and evaluating RTK inhibitor–temozolomide combinations in genetically defined glioma models.
-
Cy5 amine (non-sulfonated) Labeling Guide
2026-08-12
Cy5 amine (non-sulfonated) provides a primary amine for covalent attachment to activated esters, carbodiimide-activated carboxy groups, and epoxides in fluorescence labeling workflows. Its strong red/far-red signal is useful for microscopy, flow cytometry, and molecular tracking, but the dye is water-insoluble and must be dissolved in an organic co-solvent before use in aqueous biomolecule buffers.
-
2-APB and the ER Calcium Cell-Fate Switch
2026-08-12
A mechanistic and translational perspective on how 2-APB can be used to dissect IP3R-dependent calcium signaling, autophagy–apoptosis transitions, and injury biology while accounting for its channel-modulating limitations.
-
Etoposide (VP-16) in DNA Damage Research
2026-08-11
Etoposide (VP-16) is a practical benchmark for inducing topoisomerase II–linked DNA double-strand breaks, apoptosis, and treatment-response phenotypes across cancer models. This guide connects soluble-cell workflows with the localized nanoparticle and hydrogel strategy reported for post-surgical brain-tumor delivery.
-
GW4064: FXR Causality in Fibrosis Assays
2026-08-11
GW4064 is a non-steroidal FXR agonist that can do more than activate a reporter. This article explains how to use it as a causal perturbation tool for connecting FXR signaling, TLR4, ferroptosis, and collagen deposition in toxicant-induced liver fibrosis models.
-
2'-O-Methyladenosine: An Assay Decision Guide
2026-08-10
2'-O-Methyladenosine is more than a modified adenosine standard: it is a useful probe for separating RNA turnover, extracellular transport, and purine metabolism. This guide translates matrix-aware UHPLC–MS/MS evidence into practical assay decisions.
-
2'-O-Methyladenosine: Workflow & Assay Guide
2026-08-09
Build more reliable RNA modification nucleoside and purine metabolism studies with a practical workflow for 2'-O-Methyladenosine. The guide connects reagent handling, cell extraction, isotope-diluted UHPLC–MS/MS, transport assays, and troubleshooting without confusing free-nucleoside measurements with transcript-level mapping.
-
α-Bungarotoxin: A Translational Blockade Strategy
2026-08-08
α-Bungarotoxin is more than a receptor antagonist: it is a mechanistic probe for testing whether α7 nicotinic acetylcholine receptor signaling connects cholinergic activity with inflammation, cell death, and tissue dysfunction. This thought-leadership guide translates recent placental findings into a rigorous experimental strategy for neuroscience, neurotoxicity research, and broader translational programs.
-
R2 Retrotransposon Insertions and DNA Repair Pathways
2026-08-07
McIntyre, Horton, and Collins show that stable R2 retrotransposon insertions in human cells can be completed through distinct DNA repair routes, producing characteristic insertion lengths and junction signatures. Using PRINT, the study separates target-primed reverse transcription from broader retrotransposon mobility and provides a mechanistic framework for interpreting intact and truncated gene insertions.
-
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-08-07
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit provides a reliable solution for high-resolution separation of low molecular weight proteins and peptides (1–10 kDa), a challenge for conventional SDS-PAGE systems. This kit is suited for research workflows requiring accurate analysis of small proteins, but is not intended for diagnostic or clinical use.
-
HEY2 Repression of Mitochondrial Genes Maintains Cardiac Hom
2026-08-06
The referenced study elucidates how the transcriptional repressor HEY2 modulates mitochondrial oxidative metabolism in the heart by repressing key metabolic genes. This mechanism links transcriptional control to energy homeostasis and heart failure, offering new insights into cardiac disease pathophysiology and potential molecular targets for intervention.